ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

DeVita Recommends Carcinogenesis Testing Program Be Moved to NIEHS

May 23, 1980

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

Upton Considers Moving Basic Research Contracts To grants; Staff Changes Possible, Newell Stay

July 22, 1977

DCCR Plans Three Multiple Contracts In Pain Control

February 17, 1978

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995

In Brief: Cancer Program “Strengthened” NIH, Report From Biomedical Research Panel Contends

April 16, 1976